Juvaris BioTherapeutics
Latest round
- Series B
Last raised
- Apr 2010
Total raised
- $66M
Investors
- 2
About Juvaris BioTherapeutics
Juvaris BioTherapeutics, Inc. is developing novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The Company is also developing vaccines for HSV-2, universal flu and pandemic flu.
Who invested in Juvaris BioTherapeutics
2 investors across 6 rounds
See all investors in Juvaris BioTherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Juvaris BioTherapeutics
Who invested in Juvaris BioTherapeutics?
Juvaris BioTherapeutics has 2 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Juvaris BioTherapeutics raised?
Juvaris BioTherapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Juvaris BioTherapeutics last raise money?
Juvaris BioTherapeutics's most recent round on record is a Series B, in Apr 2010.
What does Juvaris BioTherapeutics do?
Juvaris BioTherapeutics is a pharmaceuticals company.
Where is Juvaris BioTherapeutics headquartered?
Juvaris BioTherapeutics is headquartered in Burlingame, US.
Which VCs invest in companies like Juvaris BioTherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Juvaris BioTherapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Juvaris BioTherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.